Home › Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho
 

Keywords :   


Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho

2016-04-10 23:14:22| Biotech - Topix.net

's stock had its "buy" rating reaffirmed by investment analysts at Mizuho in a research report issued on Sunday, Marketbeat.com reports. They presently have a $130.00 target price on the biopharmaceutical company's stock.

Tags: rating sciences gilead mizuho

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.06Berry, Glatfelter Merger Reaches Regulator Milestone
27.06IT expert 'pressurised' by Post Office over evidence
27.06Ahlstrom Introduces Fluouro-Free Technology in Filtration Applications
27.06Eastern North Pacific Tropical Weather Outlook
27.06Atlantic Tropical Weather Outlook
27.06Automation aids in classifying truck sanitation status
27.06Texas Disposals Gregory Transforms Ideas Into Real World Plans
27.06Anaergia Appoints Assaf Onn as Acting CEO
More »